Secondary interventions in patients with autologous infrainguinal bypass grafts strongly improve patency rates.
OBJECTIVE
To describe the patency of percutaneous transluminal angioplasty (PTA) of autologous infrainguinal bypasses at risk.


METHODS
This was a retrospective single-center cohort study of consecutive patients who underwent primary PTA of an infrainguinal autologous bypass at risk from January 2009 to December 2013. Duplex ultrasound surveillance was performed for at least 1 year after PTA. The primary study end point was the number of secondary interventions. Secondary end points were freedom from recurrent stenosis or bypass occlusion and the patency of the infrainguinal autologous bypass at 1 year after primary PTA.


RESULTS
A total of 69 infrainguinal bypasses at risk in 69 patients were identified and treated with PTA. Technical success was achieved in 91%. The median follow-up was 17 months (range, 1-58 months). During follow-up, 30 bypasses (43%) remained free of significant stenosis or bypass occlusion, 29 bypasses (42%) developed recurrent stenosis, and 10 bypasses (14%) occluded. Rates of primary assisted, and secondary patency at 1 year were 84%, and 86%. Five (7%) major amputations were performed, all after bypass occlusion.


CONCLUSIONS
Secondary interventions after PTA of a bypass at risk are common. However, repeated secondary interventions of autologous infrainguinal bypasses at risk result in patency rates of more than 80% at 1 year.
Department of Vascular Surgery, Maasstad Hospital, Rotterdam, The Netherlands. Electronic address: jongsmah@maasstadziekenhuis.nl.
Hidde
H
Jongsma
Department of Vascular Surgery, Maasstad Hospital, Rotterdam, The Netherlands.
Joost A
JA
Bekken
Department of Vascular Surgery, Maasstad Hospital, Rotterdam, The Netherlands.
Fons
F
van Buchem
Department of Vascular Surgery, Maasstad Hospital, Rotterdam, The Netherlands.
Wouter J J
WJ
Bekkers
Department of Radiology, Maasstad Hospital, Rotterdam, The Netherlands.
Fahim
F
Azizi
Department of Vascular Surgery, Maasstad Hospital, Rotterdam, The Netherlands.
Bram
B
Fioole
D000368:Aged; D000369:Aged, 80 and over; D000671:Amputation, Surgical; D000800:Angioplasty, Balloon / Q000009:adverse effects / Q000295:instrumentation; D064592:Autografts; D005260:Female; D006083:Graft Occlusion, Vascular / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D053208:Kaplan-Meier Estimate; D023821:Limb Salvage; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D058729:Peripheral Arterial Disease / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery*; D012008:Recurrence; D012086:Reoperation; D012189:Retrospective Studies; D012307:Risk Factors; D015607:Stents; D013997:Time Factors; D016896:Treatment Outcome; D018616:Ultrasonography, Doppler, Duplex; D058017:Vascular Grafting / Q000009:adverse effects*; D014654:Vascular Patency